ArticleFrontiers in oncology2022

Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients Receiving Heat Shock Protein Peptide Complex 96 Vaccination.

Yi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.